Publications by authors named "Rizvi H"

This pictorial review provides a comprehensive visual and textual overview of interventional radiology approaches in treating complicated appendicitis and other abdominal abscesses in children. This review discusses the incidence and complications associated with appendicitis in pediatric patients, highlighting the role of percutaneous drainage in managing appendicitis with abscesses. We present common mimics of intra-abdominal abscesses from other diseases such as tubo-ovarian abscesses, inflammatory bowel disease, and lymphomatous bowel involvement, emphasizing imaging pitfalls that can mimic appendiceal abscesses.

View Article and Find Full Text PDF

PURPOSEThe impact of the intratumoral microbiome on immune checkpoint inhibitor (ICI) efficacy in patients with non-small-cell lung cancer (NSCLC) is unknown. Preclinically, intratumoral Escherichia is associated with a proinflammatory tumor microenvironment and decreased metastases. We sought to determine whether intratumoral Escherichia is associated with outcome to ICI in patients with NSCLC.

View Article and Find Full Text PDF

In this work, pure and S-N/WO3 (1%-7%) nanoparticles (NPs) have been developed for the degradation of MB dye. Optical properties, vibrational analysis, morphology, structural analysis, and photocatalytic activity of the samples have been evaluated using a variety of characterization techniques, including UV-vis, PL, FTIR, SEM, and x-ray diffraction (XRD). The XRD patterns showed that the stability of the orthorhombic phase of WO3 was affected by the concentrations of S and N.

View Article and Find Full Text PDF

Meige syndrome (MS) is a cranial dystonia that involves blepharospasm and oromandibular dystonia. It can also evolve to include other adjacent muscle groups in the cervical region. It typically presents in middle-aged females, and while the disorder is relatively uncommon, its exact prevalence varies.

View Article and Find Full Text PDF

Meningitis is the inflammation of meninges either septic or aseptic depending on the source of infection. Typical signs and symptoms of meningitis in children include fever, headache, neck stiffness, nuchal rigidity represented by positive Kernig and Brudzinski signs, photophobia, nausea, vomiting, confusion, lethargy, and irritability. Bacterial meningitis is commonly caused by  in children over the age of three months.

View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy using PD-(L)1 blockade is common for treating non-small cell lung cancer (NSCLC), but over 60% of initial responders develop acquired resistance.
  • Research indicates that this resistance is linked to differences in inflammation and interferon (IFN) signaling, with relapsed tumors showing varied expressions of IFNγ response genes.
  • Understanding the altered IFN response in these tumors may help develop new strategies to overcome resistance and improve treatment effectiveness.
View Article and Find Full Text PDF

This review synthesises past research into how machine and deep learning can improve the cyto- and histopathology processing pipelines for thyroid cancer diagnosis. The current gold-standard preoperative technique of fine-needle aspiration cytology has high interobserver variability, often returns indeterminate samples and cannot reliably identify some pathologies; histopathology analysis addresses these issues to an extent, but it requires surgical resection of the suspicious lesions so cannot influence preoperative decisions. Motivated by these issues, as well as by the chronic shortage of trained pathologists, much research has been conducted into how artificial intelligence could improve current pipelines and reduce the pressure on clinicians.

View Article and Find Full Text PDF

Withdrawal is believed to play a central role in the brain disease model of addiction. However, little research describes withdrawal-motives among untreated individuals in community settings. This cross-sectional study surveyed syringe exchange program participants ( = 139) with untreated opioid use disorder (OUD) in Columbus, Ohio from January 10th to March 25th, 2023, to assess their perceptions of the role of withdrawal in OUD maintenance, treatment delay, and OUD's refractoriness to buprenorphine.

View Article and Find Full Text PDF

Background: Direct KRASG12C inhibitors are approved for patients with non-small cell lung cancers (NSCLC) in the second-line setting. The standard-of-care for initial treatment remains immune checkpoint inhibitors, commonly in combination with platinum-doublet chemotherapy (chemo-immunotherapy). Outcomes to chemo-immunotherapy in this subgroup have not been well described.

View Article and Find Full Text PDF
Article Synopsis
  • A study compared the effectiveness of single-agent PD-(L)1 blockade therapy (IO) versus a combination of chemotherapy and PD-(L)1 blockade (Chemotherapy-IO) in patients with advanced lung adenocarcinomas (LUADs) who had PD-L1 expression of 1% or more.
  • The results showed that Chemotherapy-IO led to a higher objective response rate (44% vs 35%) and longer progression-free survival compared to IO alone, particularly in patients with higher PD-L1 expression.
  • However, only never-smokers with PD-L1 expression of 50% or more showed a significant survival benefit from the combination treatment, while patients with very high PD-L1 expression (
View Article and Find Full Text PDF

Purpose: We sought to identify features of patients with advanced non-small cell lung cancer (NSCLC) who achieve long-term response (LTR) to immune checkpoint inhibitors (ICI), and how these might differ from features predictive of short-term response (STR).

Experimental Design: We performed a multicenter retrospective analysis of patients with advanced NSCLC treated with ICIs between 2011 and 2022. LTR and STR were defined as response ≥ 24 months and response < 12 months, respectively.

View Article and Find Full Text PDF

Introduction: Although gene-level copy number alterations have been studied as a potential biomarker of immunotherapy efficacy in NSCLC, the impact of aneuploidy burden and chromosomal arm-level events on immune checkpoint inhibitor (ICI) efficacy in NSCLC is uncertain.

Methods: Patients who received programmed cell death protein 1 or programmed death-ligand 1 (PD-L1) inhibitor at two academic centers were included. Across all 22 chromosomes analyzed, an arm was considered altered if at least 70% of its territory was either gained or deleted.

View Article and Find Full Text PDF

Purpose: We describe the clinical and genomic landscape of the non-small cell lung cancer (NSCLC) cohort of the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) Biopharma Collaborative (BPC).

Experimental Design: A total of 1,846 patients with NSCLC whose tumors were sequenced from 2014 to 2018 at four institutions participating in AACR GENIE were randomly chosen for curation using the PRISSMM data model. Progression-free survival (PFS) and overall survival (OS) were estimated for patients treated with standard therapies.

View Article and Find Full Text PDF

Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we describe here the first joint analysis of the Stand Up To Cancer-Mark Foundation cohort, a resource of whole exome and/or RNA sequencing from 393 patients with NSCLC treated with anti-PD-(L)1 therapy, along with matched clinical response annotation. We identify a number of associations between molecular features and outcome, including (1) favorable (for example, ATM altered) and unfavorable (for example, TERT amplified) genomic subgroups, (2) a prominent association between expression of inducible components of the immunoproteasome and response and (3) a dedifferentiated tumor-intrinsic subtype with enhanced response to checkpoint blockade.

View Article and Find Full Text PDF
Article Synopsis
  • Paired single-cell RNA and T cell receptor sequencing (scRNA/TCR-seq) was used to analyze T cell dynamics in non-small cell lung cancer after immune checkpoint blockade, focusing on 187,650 T cells from various tissue regions.
  • The findings indicated that regions with active tumors had high levels of exhausted CD8 T cells, regulatory CD4 T cells (Tregs), and follicular helper T cells (TFH), showing changes in T cell populations based on their location relative to the tumor.
  • The study also tracked specific T cell clones over time, finding that tumor-specific T cells persist in the bloodstream for years following treatment, demonstrating a long-lasting immune response post-therapy.
View Article and Find Full Text PDF
Article Synopsis
  • * Analysis of 440 lung cancer samples showed that CD39+ CD8 T cells were linked to features like exhaustion and tumor reactivity, but only weakly associated with other tumor characteristics like PD-L1 and mutation burden.
  • * Increased levels of CD39+ CD8 T cells due to immune checkpoint blockade (ICB) were linked to better outcomes in ICB therapy, with a specific gene signature predicting benefits from ICB but not from chemotherapy in non-small cell lung cancer trials.
View Article and Find Full Text PDF
Article Synopsis
  • The RAS family of GTPases, often mutated in various cancers, was analyzed across 66,372 tumors to understand how RAS mutations affect other genes and overall cancer characteristics.
  • The study revealed that RAS mutations show different patterns of co-mutations with non-RAS genes, influenced by the type of cancer, patient demographics, and genetic factors, particularly noting distinctions in KRAS G12C-mutant lung cancer.
  • Findings suggest that understanding the genomic differences in RAS-mutant tumors can help develop targeted therapies and improve clinical outcomes, especially with immunotherapy strategies.
View Article and Find Full Text PDF
Article Synopsis
  • - Accurate understanding of genetic ancestry is essential for addressing cancer disparities, and new methods using clinical sequencing panels allow for better integration of ancestry analysis in diagnostic settings.
  • - In a study of over 45,000 cancer patients, researchers found that ancestry influences the frequency of genetic mutations, revealing some known and novel associations, as well as differences in clinically actionable alterations.
  • - Despite similar rates of key genetic changes by ancestry group, a lower percentage of patients with African ancestry had actionable alterations compared to those with European ancestry, highlighting inequities in how precision oncology serves different populations.
View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy is commonly used for advanced non-small cell lung cancer (NSCLC), but accurately predicting who will respond to it remains difficult.
  • The study analyzed data from 247 patients, combining medical imaging, histopathology, and genomic features to improve predictions about immunotherapy responses.
  • The proposed multimodal model significantly outperformed traditional single-method measures, showing a strong predictive capacity (AUC = 0.80) and highlighting the value of using multiple data types in patient assessments.
View Article and Find Full Text PDF

Purpose: Clinical patterns and the associated optimal management of acquired resistance to PD-(L)1 blockade are poorly understood.

Experimental Design: All cases of metastatic lung cancer treated with PD-(L)1 blockade at Memorial Sloan Kettering were reviewed. In acquired resistance (complete/partial response per RECIST, followed by progression), clinical patterns were distinguished as oligo (OligoAR ≤ 3 lesions of disease progression) or systemic (sAR).

View Article and Find Full Text PDF

is an opportunistic fungal pathogen of humans, yet the within-host dynamics of infection are not clear. While is commonly diploid, it exhibits a range of ploidies, including tetraploidy. Previous work found that tetraploid populations exhibited rapid adaptation and significant genome instability when evolved .

View Article and Find Full Text PDF

Importance: Although tumor mutation burden (TMB) has been explored as a potential biomarker of immunotherapy efficacy in solid tumors, there still is a lack of consensus about the optimal TMB threshold that best discriminates improved outcomes of immune checkpoint inhibitor therapy among patients with non-small cell lung cancer (NSCLC).

Objectives: To determine the association between increasing TMB levels and immunotherapy efficacy across clinically relevant programmed death ligand-1 (PD-L1) levels in patients with NSCLC.

Design, Setting, And Participants: This multicenter cohort study included patients with advanced NSCLC treated with immunotherapy who received programmed cell death-1 (PD-1) or PD-L1 inhibition in the Dana-Farber Cancer Institute (DFCI), Memorial Sloan Kettering Cancer Center (MSKCC), and in the Stand Up To Cancer (SU2C)/Mark Foundation data sets.

View Article and Find Full Text PDF

Background: 'Stable disease (SD)' as per RECIST is a common but ambiguous outcome in patients receiving immune checkpoint inhibitors (ICIs). This study aimed to characterize SD and identify the subset of patients with SD who are benefiting from treatment. Understanding SD would facilitate drug development and improve precision in correlative research.

View Article and Find Full Text PDF

Background: The genetic factors that modulate risk for developing lung cancer have not been fully defined. Here, we sought to determine the prevalence and clinical significance of germline pathogenic/likely pathogenic variants (PV) in patients with advanced lung cancer.

Methods: We studied clinical and tumor characteristics of germline PV in 5,118 patients who underwent prospective genomic profiling using paired tumor-normal tissue samples in 468 cancer genes.

View Article and Find Full Text PDF